Form of Agreement for Escrow Arrangements under National Policy 46-201 Escrow for Initial Public OfferingsEscrow Agreement • November 13th, 2013 • Pacific Therapeutics Ltd. • Pharmaceutical preparations • British Columbia
This Agreement is being entered into by the Parties under National Policy 46-201 Escrow for Initial Public Offerings (the Policy) in connection with the Issuer becoming a reporting issuer in British Columbia and the proposed listing of its class A common shares on the Canadian National Stock Exchange.
CREDIT AGREEMENTCredit Agreement • October 27th, 2022 • Tower One Wireless Corp. • Telephone communications (no radiotelephone)
Borrower and Lender shall collectively be known herein as "the Parties". In determining the rights and duties of the Parties under the Credit Agreement, the entire document must be read as a whole.
TOWER ONE WIRELESS CORP. as the Corporation and COMPUTERSHARE TRUST COMPANY OF CANADA as the Warrant AgentWarrant Indenture • March 28th, 2018 • Tower One Wireless Corp. • Pharmaceutical preparations • British Columbia
TOWER ONE WIRELESS CORP., a corporation incorporated under the laws of the Province of British Columbia (the “Corporation”),
ContractWarrant Agreement • November 13th, 2013 • Pacific Therapeutics Ltd. • Pharmaceutical preparations • British Columbia
THIS WARRANT AND THE COMMON SHARES ACQUIRABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER ANY SECURITIES ACT OR THE SECURITIES LAWS OF ANY PROVINCE OR STATE. THIS WARRANT MAY NOT BE EXERCISED UNLESS THE WARRANT AND THE UNDERLYING SHARES HAVE BEEN REGISTERED UNDER THE SECURITIES ACT AND THE APPLICABLE SECURITIES LEGISLATION OF ANY SUCH JURISDICTION OR AN EXEMPTION FROM SUCH REGISTRATION REQUIREMENTS IS AVAILABLE.
Escrow AgreementEscrow Agreement • February 6th, 2019 • Tower One Wireless Corp. • Pharmaceutical preparations • British Columbia
AMONG: TOWER ONE WIRELESS CORP. (formerly, Pacific Therapeutics Ltd.), a company duly incorporated under the laws of British Columbia, having its registered and records office at Suite 605, 815 Hornby St., Vancouver BC. V6Z 2E6
Certain information has been omitted from the following agreement because such information is both not material to investors and would be competitively harmful to the registrant. Such omitted information has been marked “[***]” DEVELOPMENT AGREEMENTDevelopment Agreement • October 15th, 2019 • Tower One Wireless Corp. • Pharmaceutical preparations • New York
THIS DEVELOPMENT AGREEMENT (this “Agreement”) is made as of February 13, 2019 (the “Effective Date”) among COMERCIALIZADORA MEXMAKEN S.A. DE C.V., a company organized and existing under the laws of Mexico (the “Developer”) and [***] , a company organized and existing under the laws of Mexico (“[***]”). Each of Developer and [***] may hereafter be referred to as a “Party”, and collectively, as the “Parties”. Capitalized terms used herein without definition shall have the meanings assigned to them in the Purchase Agreement.
PACIFIC THERAPEUTICS LTD. STOCK OPTION AGREEMENTStock Option Agreement • November 13th, 2013 • Pacific Therapeutics Ltd. • Pharmaceutical preparations • British Columbia
DEVELOPMENT AND COMMERCIALISATION AGREEMENTDevelopment and Commercialisation Agreement • November 13th, 2013 • Pacific Therapeutics Ltd. • Pharmaceutical preparations • Ontario
THIS DEVELOPMENT AND COMMERCIALISATION AGREEMENT (this "Agreement") is made and entered into as of February 28, 2011 (the "Effective Date"), by and between IntelGenx Corp., a Canadian corporation ("lntelGenx"), and Pacific Therapeutics Ltd., a Canadian company ("Pacific"). IntelGenx and Pacific each may be referred to herein individually as a "Party," or collectively as the "Parties".
EMPLOYMENT AGREEMENTEmployment Agreement • November 13th, 2013 • Pacific Therapeutics Ltd. • Pharmaceutical preparations • British Columbia
Pacific Therapeutics Ltd., a company incorporated pursuant to the laws of the Province of British Columbia and having a business office at Suite 1023 – 409 Granville Street, Vancouver, B.C., V6C 1T2
CREDIT AGREEMENTCredit Agreement • August 24th, 2018 • Tower One Wireless Corp. • Pharmaceutical preparations
This credit agreement is made on the day of September 27, 2017 by and among, EXECUTIVE INVESTMENT PARTNERS, LLC., FLORIDA LIMITED LIABILITY COMPANY, 15001 NW 42nd Avenue, Suite # 203, MIAMI, FL, 33054. Hereinafter known as “Lender”.
Amended and Restated ARRANGEMENT AGREEMENTArrangement Agreement • September 12th, 2017 • Tower One Wireless Corp. • Pharmaceutical preparations • British Columbia
WHEREAS PT and Newco entered into an arrangement agreement on April 18, 2016 and they wish to amend the same and restate said agreement in its entirety by including the amendments to the same,
Loan AgreementLoan Agreement • May 19th, 2022 • Tower One Wireless Corp. • Telephone communications (no radiotelephone)
Pursuant to the Loan Agreement, Fideicomiso Tower II (the "debtor"), Tower (the "codebtors"), and Itaú (the "lender"), establish a Loan Agreement, pursuant to which Itaú will lend funds for the purpose of constructing cellphone Towers. The loan amount is for up to COP 40,463,000,000.00 (USD 10.2MM). Commerk, is committed to disburse up to COP 13,487,666,666.67 (USD 3.4MM) ("Commerk disbursement").
Tower One Wireless Corp. ("Tower One Wireless") Collaboration Agreement with Commerk S.A.S. Year ended December 31, 2021Collaboration Agreement • May 19th, 2022 • Tower One Wireless Corp. • Telephone communications (no radiotelephone)
Effective date: April 6, 2021 Parties: Tower 3 S.A.S. ("Tower"), Tower One Wireless, and Commerk S.A.S. ("Commerk") Terms: Pursuant to the Collaborative Agreement, Tower and Commerk (together, the "Parties"), establish a Joint Venture, pursuant to which they shall make Contributions provided for in the Collaboration Agreement for the purpose of designing, developing, financing, constructing, operating (where applicable), maintaining and exploiting each Project in accordance with the Project Documents, share the risk and benefits and receive the Shares arising from the Joint Venture. Project: Each group of Telecommunication Towers developed pursuant to the Common Transaction and whose associated Customer Contracts will guarantee the cash flows that, with respect to each Project, will be transferred to a Project AP (defined below) to serve as collateral for the respective Financial Closing (disbursement of remaining funds upon completion of Projects). Ownership percentage: Tower owns 50%
EXECUTION COPYPromissory Note • October 27th, 2022 • Tower One Wireless Corp. • Telephone communications (no radiotelephone) • British Columbia
THIS NOTE HAS NOT BEEN REGISTERED UNDER APPLICABLE SECURITIES LAWS. THIS THIS NOTE MAY NOT BE SOLD, PLEDGED, TRANSFERRED, ENCUMBERED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO APPLICABLE SECURITIES LAWS.
LOAN AGREEMENTLoan Agreement • October 27th, 2022 • Tower One Wireless Corp. • Telephone communications (no radiotelephone) • British Columbia
This Loan Agreement ("Loan Agreement" or "Agreement") is made and entered as of the 30th day of September 2019 ("Effective Date") , between Hugo Ochoa, with address 5301 NW 74th Avenue, Miami, FL 33166 (the "Lender"), and TOWER ONE WIRELESS CORP., a British Columbia (Canada) company (The "Borrower" or the "Company") with address in 600 - 535 Howe Street, Vancouver, BC V6C 2Z4, Canada.
Loan AgreementLoan Agreement • May 19th, 2022 • Tower One Wireless Corp. • Telephone communications (no radiotelephone)
Pursuant to the Loan Agreement, Fideicomiso Tower (the "debtor"), Tower and Commerk (together, the "codebtors"), and Itaú (the "lender"), establish a Loan Agreement, pursuant to which Itaú will lend funds for the purpose of constructing cellphone Towers. The loan amount is for up to COP 31,632,000,000.00 (USD 7.9MM). Commerk, is committed to disburse up to COP 10,544,000,000.00 (USD 2.7MM) ("Commerk disbursement").
CREDIT AGREEMENTCredit Agreement • August 24th, 2018 • Tower One Wireless Corp. • Pharmaceutical preparations
This credit agreement is made on the day of October 1, 2017 by and among, Hugo L Ochoa, a resident of Miami, Florida. Hereinafter known as “Lender”.
TOWER ONE TO ACQUIRE ARGENTINA MASTER LEASE AGREEMENTShare Purchase Agreement • September 29th, 2017 • Tower One Wireless Corp. • Pharmaceutical preparations
Vancouver, BC, Canada – May 23, 2017 – Tower One Wireless Corp (CSE: TO) (OTC: TOWTF) (Frankfurt: A2DKQ4) (“Tower One” or the “Company”) announces it entered into a share purchase agreement to acquire 65 per cent of the issued and outstanding shares of a private Tower Company (the “Tower Company”).
SHARE EXCHANGE AGREEMENTShare Exchange Agreement • September 12th, 2017 • Tower One Wireless Corp. • Pharmaceutical preparations
NOW THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
ContractPurchase Agreement • August 24th, 2018 • Tower One Wireless Corp. • Pharmaceutical preparations
PURCHASE AGREEMENT OF ACTIONS CELEBRATING ON THE ONE PART THE C. JAVIER EDUARDO REV PEDRAZA, WHO IN THE SUCCESSIVE WILL BE DENOMINATED "THE SELLER" V BY THE OTHER TOWER ONE WIRELESS CORP., REPRESENTED IN THIS ACT BY C. MIGUEL ANGEL CARDONA B., TO WHOM SUCCESSIVE IT WILL BE DENOMINATED "THE BUYER", WITH THE COMPARISON OF ENRIQUE SANCHEZ HERNANDEZ, AT THE TENOR OF THE FOLLOWING:
CREDIT AGREEMENTCredit Agreement • October 27th, 2022 • Tower One Wireless Corp. • Telephone communications (no radiotelephone) • British Columbia
This credit agreement is made on the day of July 26, 2018 by and among, EXECUTIVE INVESTMENT PARTNERS, LLC., FLORIDA LIMITED LIABILITY COMPANY, 14900 NW 42nd Avenue, Suite # 108, MIAMI, FL 33054. Hereinafter known as "Lender".
EXECUTION COPYPromissory Note • October 27th, 2022 • Tower One Wireless Corp. • Telephone communications (no radiotelephone) • British Columbia
THIS NOTE HAS NOT BEEN REGISTERED UNDER APPLICABLE SECURITIES LAWS. THIS THIS NOTE MAY NOT BE SOLD, PLEDGED, TRANSFERRED, ENCUMBERED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO APPLICABLE SECURITIES LAWS.
PACIFIC THERAPEUTICS SIGNS DEFINATIVE AGREEMENT TO SELL FIBROSIS AND ERECTILE DYSFUNCTION THERAPEUTICS TECHNOLOGIESDefinitive Agreement • April 7th, 2017 • Tower One Wireless Corp. • Pharmaceutical preparations
VANCOUVER, BC, Canada –July 24, 2015 – Pacific Therapeutics Ltd. (CSE: PT) (OTC Markets: PCFTF) (Frankfurt: 1P3) (the “Company”) is a clinical stage specialty pharmaceutical company focused on the repurposing and reformulation of existing FDA approved drugs for large markets. The Company’s research programs have focused on diseases of excessive scarring (fibrosis) and erectile dysfunction (ED).
DEVELOPMENT AND COMMERCIALISATION AGREEMENTDevelopment and Commercialisation Agreement • April 30th, 2014 • Pacific Therapeutics Ltd. • Pharmaceutical preparations • British Columbia
THIS DEVELOPMENT AND COMMERCIALISATION AGREEMENT (this "Agreement") is made and entered into as of October 22, 2013 (the "Effective Date"), by and between Globe Labs Inc., a Canadian corporation ("Globe"), and Pacific Therapeutics Ltd., a Canadian company ("Pacific"). Globe and Pacific each may be referred to herein individually as a "Party," or collectively as the "Parties".
ESCROW AGREEMENTEscrow Agreement • August 24th, 2018 • Tower One Wireless Corp. • Pharmaceutical preparations
This Escrow Agreement (“Agreement”) is made and entered into as of this 18th day of October, 2017, by and between Tower Construction & Technical Services, Inc. (“TCTS”), and its shareholders, Angel Hernandez (“Hernandez”) and Harold Ramirez (“Ramirez”) (Hernandez and Ramirez collectively referred to as the “Shareholders”), Tower One Wireless Corp. (“Tower”), (hereinafter collectively referred to the “Parties”) and The Josephs Law Finn (“Escrow Agent”).
